Prospect Capital Advisors’s SkinHealth Systems SKIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-285,900
Closed -$1.72M 32
2023
Q3
$1.72M Sell
285,900
-304,500
-52% -$2.14M 0.73% 27
2023
Q2
$4.94M Buy
590,400
+539,100
+1,051% +$5.6M 1.87% 23
2023
Q1
$648K Sell
51,300
-128,450
-71% -$1.49M 0.29% 29
2022
Q4
$1.64M Sell
179,750
-288,400
-62% -$3.11M 0.85% 23
2022
Q3
$5.52M Buy
468,150
+47,750
+11% +$604K 2.91% 16
2022
Q2
$5.41M Buy
420,400
+164,200
+64% +$2.2M 2.74% 15
2022
Q1
$4.33M Buy
256,200
+25,450
+11% +$420K 2.01% 17
2021
Q4
$5.58M Sell
230,750
-25,450
-10% -$656K 2.19% 17
2021
Q3
$6.65M Buy
+256,200
New +$5.63M 2.2% 17

Other funds holding SKIN

Prospect Capital Advisors's SKIN Position: Q4 2023 in Review

Prospect Capital Advisors sold out of SkinHealth Systems (SKIN) in Q4 2023, closing a stake of 285,900 shares — an estimated $1.72M sold.

Prospect Capital Advisors first reported a position in SKIN in Q3 2021 and held it in 9 quarters. The position peaked at $6.65M in Q3 2021. 130 funds tracked by Wall St. Rank hold SKIN as of Q4 2023.

  • Prospect Capital Advisors reported no remaining SkinHealth Systems position as of Q4 2023 after selling out during the quarter.
  • Prospect Capital Advisors sold 285,900 SkinHealth Systems shares in Q4 2023, an estimated $1.72M.
  • Prospect Capital Advisors first reported a position in SkinHealth Systems in Q3 2021 and held it in 9 quarters.
  • Prospect Capital Advisors's SkinHealth Systems position peaked at $6.65M in Q3 2021.
  • 130 funds tracked by Wall St. Rank held SkinHealth Systems as of Q4 2023.

Based on Prospect Capital Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.